Articles

Find an Article

Filter articles

Showing 641 to 650 of 670 results

A new framework: challenging patents in changing times

01-01-2012Eldora Ellison and Eric Steffe

The America Invents Act was signed into law in September 2011, and many biotech companies are still trying to make sense of the new legislation. Eldora Ellison and Eric Steffe consider one of the most important changes.

Formal obligations: burdens on biotech patents

01-01-2012

The patentability of biotech inventions should meet substantive requirements such as novelty, inventive step and industrial applicability, but EPO developments suggest that formalities are increasingly important.

A brave new world for supplementary protection certificates?

01-01-2012Mike Snodin and Michael Pears

Advocate-General Verica Trstenjak has delivered an opinion in the case of Neurim Pharmaceuticals that, if followed by the Court of Justice of the EU, will profoundly liberalise the law governing SPCs in Europe.

Is there life for medical diagnostic patents after Prometheus?

01-01-2012MaryAnne Armstrong

The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong, PhD, explains.

Life sciences in Europe: the key jurisdictions

01-05-2011

The European life sciences industry has a long history. Many of the major players trace their roots to before the war, and often began as agricultural or chemical companies. LSIPR takes a look at the leading jurisdictions.

Covering all the bases: An interview with BIO President Jim Greenwood

01-05-2011

BIO represents a broad constituency of biotechnology and life sciences companies. LSIPR talks to BIO president and CEO Jim Greenwood about patent reform, healthcare, court cases and plans for the future.

For better, for worse? How shifting IP laws change the global life sciences regulatory chessboard

01-05-2011

With IP laws around the world subject to frequent and sometimes unpredictable changes, it can be difficult to keep abreast of everything you need to know. Richard Gough and Jane Woodhouse take a look.

It’s good to litigate a patent or two

01-05-2011

Europe is home to many life sciences companies, so IP regimes throughout the continent’s jurisdictions need to provide cost-effective, speedy and certain litigation environments if patent disputes are to be satisfactorily settled.

Building operative partnerships with law enforcement

01-05-2011Vaughn Volpi

There is a perfect storm brewing in the healthcare industry. Over the past few years, there has been an unprecedented rise in the trade of illicit healthcare products in the secondary market.

Practice points in Israel patent prosecution: selection patents and treatment of earlier-filed patent applications

Israel01-05-2011Moshe Tritel

Israel patent practice is distinct from US and European practice in a number of respects. Moshe Tritel describes a number of such areas with important practical ramifications for applicants seeking to maximise their patent protection in Israel.

Showing 641 to 650 of 670 results

LSIPR